Skip to main content

Table 1 Demographics at baseline

From: Randomized clinical trial of low dose suramin intravenous infusions for treatment of autism spectrum disorder

 

Placebo N = 18

10 mg N = 15

20 mg N = 19

Total N = 52

Age (years)

 N

18

15

19

52

 Mean (SD)

7.8 (3.1)

6.9 (2.2)

8.9 (3.7)

7.9 (3.2)

 Range (min, max)

4, 13

4, 11

4, 15

4, 15

 Quartiles (25th, median, 75th)

5, 8, 10

5, 7, 8

6, 8, 11

5, 8, 10

Race, n (%)

 Black

7 (39)

8 (53)

7 (37)

22(42)

 White

7 (39)

5 (33)

8 (42)

20(38)

 Mixed race

3 (17)

2 (13)

3 (16)

8(15)

 Asian

1 (6)

0

0

1 (2)

 Indian

0

0

1 (5)

1 (2)

Weight (kg)

 N

18

15

19

52

 Mean (SD)

30.55 (10.15)

27.57 (7.32)

38.23 (16.97)

32.50 (13.09)

 Range (min, max)

15.1, 49.2

18.6, 46.3

18.5, 81.4

15.1, 81.4

 Quartiles (25th, median, 75th)

23.1, 29.2, 40.9

22.7, 26.1, 28.1

25.0, 32.2, 46.9

23.6, 29.0, 38.2

ADOS-2

 N

18

15

19

52

 Mean (SD)

8.1 (1.5)

8.1 (1.3)

8.3 (1.4)

8.2 (1.4)

 Range (min, max)

6, 10

6, 10

6, 10

6, 10

 Quartiles (25th, median, 75th)

7, 8, 9

7, 8, 9

7, 8, 10

7, 8, 9

NVIQ

 N

18

15

19

52

 Mean (SD)

67.4 (26.2)

68.3 (29.6)

67.6 (29.0)

67.7 (27.6)

 Range (min, max)

30, 124

30, 119

30, 112

30, 124

 Quartiles (25th, median, 75th)

39, 71, 85

39, 65, 100

39, 75, 93

39, 72, 88

  1. Column header counts and denominators are the number of subjects in the ITT population